NCT05446935View on ClinicalTrials.gov

Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence

NARecruitingINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2025

Conditions

Thymic Epithelial Tumor

Interventions

PROCEDURE

HITOC

Doxorubicin(dose: 25mg/m2) + Cisplatin(dose: 50mg/m2).

Trial Locations (1)

200032

RECRUITING

Shanghai Zhongshan Hospital, Shanghai

All Listed Sponsors

lead

Shanghai Zhongshan Hospital

OTHER